BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14656714)

  • 1. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
    Sung CK; She H; Xiong S; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
    Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
    J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
    Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; IƱiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
    Moon SK; Cha BY; Kim CH
    J Cell Physiol; 2004 Mar; 198(3):417-27. PubMed ID: 14755547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells.
    Cohen M; Meisser A; Haenggeli L; Bischof P
    Mol Hum Reprod; 2006 Apr; 12(4):225-32. PubMed ID: 16520344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium.
    Chen NG; Han X
    Biochem Biophys Res Commun; 2001 Apr; 282(3):717-22. PubMed ID: 11401521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis.
    Vona-Davis L; Yu A; Magabo K; Evans T; Jackson B; Riggs D; McFadden D
    J Am Coll Surg; 2004 Jul; 199(1):87-95. PubMed ID: 15217635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signal transduction pathways.
    Kishore R; Luedemann C; Bord E; Goukassian D; Losordo DW
    Circ Res; 2003 Nov; 93(10):932-40. PubMed ID: 14576193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth.
    Xu J; Fu Y; Chen A
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G20-30. PubMed ID: 12660143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of matrix metalloproteinase-1 gene transcription by tumour necrosis factor alpha via the p50/p50 homodimer of nuclear factor-kappa B in activated human hepatic stellate cells.
    Hozawa S; Nakamura T; Nakano M; Adachi M; Tanaka H; Takahashi Y; Tetsuya M; Miyata N; Soma H; Hibi T
    Liver Int; 2008 Dec; 28(10):1418-25. PubMed ID: 19055644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells.
    Ceni E; Crabb DW; Foschi M; Mello T; Tarocchi M; Patussi V; Moraldi L; Moretti R; Milani S; Surrenti C; Galli A
    Gastroenterology; 2006 Oct; 131(4):1235-52. PubMed ID: 17030193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
    Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.